Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy
Status:
Not yet recruiting
Trial end date:
2027-04-03
Target enrollment:
Participant gender:
Summary
Evaluating Immunosuppressive treatment (Mycophenolate mofetil and prednisolon compared to
placebo) for 6 months in patients with chronic virus- Negative Inflammatory cardiomyopathy -
a multicenter, randomized, double-blind, placebo-controlled trial.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
LMU Klinikum
Collaborators:
Charite University, Berlin, Germany Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) Technical University of Munich University Hospital Erlangen University Hospital Tuebingen University Hospital, Essen